119 related articles for article (PubMed ID: 8891056)
1. CD8 and CD4 T cell-mediated polymyositis complicating the HTLV-1 associated myelopathy. Quantitative evaluation of corticosteroid treatment.
Waclawik AJ; Fadic R; Lotz BP; Beinlich BR; Lewandoski PJ; Sanjak M; Brooks BR
Acta Neurol Scand; 1996 Aug; 94(2):115-9. PubMed ID: 8891056
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of HTLV-1 associated dermato-polymyositis. Seven cases from Martinique.
Smadja D; Bellance R; Cabre P; Arfi S; Vernant JC
Acta Neurol Scand; 1995 Sep; 92(3):206-12. PubMed ID: 7484073
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical characteristics of polymyositis in patients with HTLV-I-associated myelopathy and HTLV-I carriers.
Higuchi I; Montemayor ES; Izumo S; Inose M; Osame M
Muscle Nerve; 1993 May; 16(5):472-6. PubMed ID: 8515755
[TBL] [Abstract][Full Text] [Related]
4. [HTLV-I associated myelopathy (HAM) complicated with chronic polymyositis].
Tanaka T; Takagi A; Kojima S; Goto J; Tanaka M
Rinsho Shinkeigaku; 1989 Jan; 29(1):102-7. PubMed ID: 2743679
[TBL] [Abstract][Full Text] [Related]
5. HTLV-I-associated myelopathy and polymyositis in a US native.
Evans BK; Gore I; Harrell LE; Arnold T; Oh SJ
Neurology; 1989 Dec; 39(12):1572-5. PubMed ID: 2586771
[TBL] [Abstract][Full Text] [Related]
6. [Potentially treatable subacute forms of infection due to the HTLV-1].
Carod-Artal FJ; Melo M; Alves R; Brenner C; del Negro MC
Rev Neurol; 2000 Jul 1-15; 31(1):32-5. PubMed ID: 10948579
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell lymphotropic virus type 1 myositis, peripheral neuropathy, and cerebral white matter lesions in the absence of spastic paraparesis.
Douen AG; Pringle CE; Guberman A
Arch Neurol; 1997 Jul; 54(7):896-900. PubMed ID: 9236579
[TBL] [Abstract][Full Text] [Related]
8. Anterior horn cell degeneration in polymyositis associated with human T lymphotropic virus Type-1 in patients from Barbados.
Corbin DO; Mora CA; Garriques S; Rodgers-Johnson P; Gibbs CJ
Am J Trop Med Hyg; 1996 Jun; 54(6):625-8. PubMed ID: 8686782
[TBL] [Abstract][Full Text] [Related]
9. Steroid-responsive myeloneuropathy in a man dually infected with HIV-1 and HTLV-I.
McArthur JC; Griffin JW; Cornblath DR; Griffin DE; Tesoriero T; Kuncl R; Gibbs CJ; Farzadegan H; Johnson RT
Neurology; 1990 Jun; 40(6):938-44. PubMed ID: 2161092
[TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
11. Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease.
Leon-Monzon M; Illa I; Dalakas MC
Ann Neurol; 1994 Oct; 36(4):643-9. PubMed ID: 7944297
[TBL] [Abstract][Full Text] [Related]
12. [A family case of HAM and HTLV-I carrier including two sisters presenting with myositis].
Hokezu Y; Higuchi I; Yanai S; Nagai M; Nagamatsu K
Rinsho Shinkeigaku; 1994 Jun; 34(6):563-8. PubMed ID: 7955714
[TBL] [Abstract][Full Text] [Related]
13. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory myopathy on HTLV-I infection: case report.
Scola RH; Werneck LC; Heinig ME; Milano JB; Almeida SM; Arruda WO
Arq Neuropsiquiatr; 2001 Mar; 59(1):119-22. PubMed ID: 11299445
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation of axial myopathy in two siblings with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Matsuura E; Yoshimura A; Nozuma S; Higuchi I; Kubota R; Takashima H
BMC Neurol; 2015 Feb; 15():18. PubMed ID: 25884435
[TBL] [Abstract][Full Text] [Related]
16. Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Porto AF; Santos SB; Muniz AL; Basilio V; Rodrigues W; Neva FA; Dutra WO; Gollob KJ; Jacobson S; Carvalho EM
J Infect Dis; 2005 Feb; 191(4):612-8. PubMed ID: 15655786
[TBL] [Abstract][Full Text] [Related]
17. HTLV-1-associated myelopathy/tropical spastic paraparesis accompanied with psoriasis.
Watanabe A; Kawajiri M; Ikezoe K; Osoegawa M; Murai H; Ochi H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jun; 221(1-2):95-7. PubMed ID: 15178221
[TBL] [Abstract][Full Text] [Related]
18. [A study of clinical symptoms, muscle pathology, therapeutic response, and prognosis of myositis in patients with HTLV-1 associated myelopathy (HAM)].
Inose M; Higuchi I; Yoshimine K; Arimura K; Osame M; Izumo S; Hokezu Y
Rinsho Shinkeigaku; 1999 Aug; 39(8):807-11. PubMed ID: 10586623
[TBL] [Abstract][Full Text] [Related]
19. Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis.
Lenzi ME; Cuzzi-Maya T; Oliveira AL; Andrada-Serpa MJ; Araújo AQ
Clin Infect Dis; 2003 Feb; 36(4):507-13. PubMed ID: 12567310
[TBL] [Abstract][Full Text] [Related]
20. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
